Vera A. Nevzorova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vera A. Nevzorova has a total of 573 co-authors. Here are the top co-authors by number of shared publications:
- Roman A. Bontsevich
FSAEI HE Mari State University, Yoshkar-Ola, Russia; FSAEI HE Belgorod State National Research University, Belgorod, Russia; Kazan State Medical Academy – Branch Campus of the FSBEI CPE Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Kazan, Russia
14 shared publications - Galina G. Ketova
South Ural State Medical University
13 shared publications - Olga G. Kompaniets
Kuban State Medical University
13 shared publications - Dmitriy Viktorovich Duplyakov
FSBEI HE «Samara State Medical University» of the Ministry of Healthcare of the Russian Federation; SBHI «V. P. Polyakov Samara Regional Clinical Cardiology Dispensary
12 shared publications - Irina M. Martynenko
Pacific State Medical University
12 shared publications - Nadezhda G. Vinogradova
Privolzhsky Research Medical University
12 shared publications
Latest Publications
- Open Access
- 26 October 2026
- Published by Publishing House OKI in Patient-Oriented Medicine and Pharmacy
- Vol. 4 (3) , 124-134
Heterogeneity of senior medical students' knowledge on COPD pharmacotherapy: results of cluster analysis within the multicenter ASCO-IV study
Introduction . Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of morbidity and mortality, requiring future physicians to have solid knowledge of diagnosis and pharmacotherapy. Objective . To assess the level of basic knowledge of senior medical students on COPD and, using cluster analysis, to identify stable competency profiles across key domains (etiology, diagnosis, pharmacotherapy, and vaccination prophylaxis). Materials and methods . As part of the fourth stage of the multicenter ASCO-IV project, an anonymous survey was conducted among 480 senior medical students from five Russian medical universities (October 2023 — May 2025). A validated original 21-item closed-ended questionnaire was used, covering etiology, diagnosis, classification, pharmacotherapy, and vaccination prophylaxis of COPD. Descriptive statistics, nonparametric tests (Kruskal-Wallis, Dunn, χ²), hierarchical cluster analysis, k-means clustering, and discriminant analysis were applied; significance was set at p < 0.05 with Bonferroni correction. Results . The median individual mean score was 65.9 % [49.4 %; 77.8 %], with significant intercenter differences (H = 102; df = 4; p < 0.0001). Four stable clusters were identified: “Students with basic knowledge” (23.5 %), “Students with fragmented knowledge” (24.2 %), “Students with a high level of knowledge” (29.6 %), and “Students with a pronounced knowledge deficit” (22.7 %). Discriminant analysis confirmed high model accuracy — 94.8 % correct classification (λ = 0.033; p < 0.001). A “clinical-pharmacological gap” was revealed: diagnostic items (1-7) were mastered at an acceptable level (mean completeness 42–92 %), whereas pharmacotherapy, especially initial maintenance therapy (items 12, 14) and antimicrobial therapy of exacerbations (items 16-19), caused persistent difficulties for most students, including the high-knowledge cluster. The association between training center and cluster type was significant (χ² = 68.25; df = 12; p < 0.001). Discussion . The identified knowledge profiles justify a transition to differentiated educational strategies: deepening complex pharmacotherapy topics for the basic-knowledge cluster, systematizing material for the fragmented-knowledge cluster, returning to the basic course for the knowledge-deficit cluster, and engaging the high-knowledge cluster in research and Olympiad activities. Study limitations include the cross-sectional design and unbalanced sample across centers. The findings are consistent with the KNOCAP-III project and indicate a systemic nature of deficits in respiratory medicine teaching.
- 26 October 2026
- Published by Publishing House OKI in Patient-Oriented Medicine and Pharmacy
- Vol. 4 (3) , 124-134
Open AccessHeterogeneity of senior medical students' knowledge on COPD pharmacotherapy: results of cluster analysis within the multicenter ASCO-IV study
Introduction . Chronic obstructive pulmonary disease (COPD) remains one of the leading causes of morbidity and mortality, requiring future physicians to have solid knowledge of diagnosis and pharmacotherapy. Objective . To assess the level of basic knowledge of senior medical students on COPD and, using cluster analysis, to identify stable competency profiles across key domains (etiology, diagnosis, pharmacotherapy, and vaccination prophylaxis). Materials and methods . As part of the fourth stage of the multicenter ASCO-IV project, an anonymous survey was conducted among 480 senior medical students from five Russian medical universities (October 2023 — May 2025). A validated original 21-item closed-ended questionnaire was used, covering etiology, diagnosis, classification, pharmacotherapy, and vaccination prophylaxis of COPD. Descriptive statistics, nonparametric tests (Kruskal-Wallis, Dunn, χ²), hierarchical cluster analysis, k-means clustering, and discriminant analysis were applied; significance was set at p < 0.05 with Bonferroni correction. Results . The median individual mean score was 65.9 % [49.4 %; 77.8 %], with significant intercenter differences (H = 102; df = 4; p < 0.0001). Four stable clusters were identified: “Students with basic knowledge” (23.5 %), “Students with fragmented knowledge” (24.2 %), “Students with a high level of knowledge” (29.6 %), and “Students with a pronounced knowledge deficit” (22.7 %). Discriminant analysis confirmed high model accuracy — 94.8 % correct classification (λ = 0.033; p < 0.001). A “clinical-pharmacological gap” was revealed: diagnostic items (1-7) were mastered at an acceptable level (mean completeness 42–92 %), whereas pharmacotherapy, especially initial maintenance therapy (items 12, 14) and antimicrobial therapy of exacerbations (items 16-19), caused persistent difficulties for most students, including the high-knowledge cluster. The association between training center and cluster type was significant (χ² = 68.25; df = 12; p < 0.001). Discussion . The identified knowledge profiles justify a transition to differentiated educational strategies: deepening complex pharmacotherapy topics for the basic-knowledge cluster, systematizing material for the fragmented-knowledge cluster, returning to the basic course for the knowledge-deficit cluster, and engaging the high-knowledge cluster in research and Olympiad activities. Study limitations include the cross-sectional design and unbalanced sample across centers. The findings are consistent with the KNOCAP-III project and indicate a systemic nature of deficits in respiratory medicine teaching.
- Open Access
- 23 September 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (10S) , 7127
Prevalence, clinical, and prognostic role of metabolic syndrome in patients with heart failure: A subanalysis of the PRIORITY-HF study
Aim. To assess the prevalence of individual components of metabolic syndrome (MS), the incidence of MS, and its clinical and prognostic significance in outpatients with heart failure (HF). Material and methods. This retrospective analysis of data from the PRIORITY-HF multicenter registry study of patients with HF in the Russian Federation was conducted. The analytical cohort included 19939 patients, and the primary and secondary criteria of MS were analyzed. A group with MS was identified according to diagnostic criteria, and combinations of components were assessed. In addition, cluster analysis was performed, and prognosis was evaluated. Results. In the analyzed cohort, the primary criteria of MS were identified with high frequency as follows: obesity in 45,6%, HTN in 89%, and type 2 diabetes in 27,4% of patients. Among the additional criteria, the highest prevalence was observed for dyslipidemia/lipid-lowering therapy in 80,7%, impaired renal function/damage in 62%, and hyperuricemia/urate-lowering therapy in only 5% of patients. MS was diagnosed in 14403 (70,4%) patients. Among patients with MS, the following distribution was noted depending on the burden of main criteria: 48,8% — 2, 28% — 1, and 23,2% — 3 main criteria. The most frequent combination was HTN + dyslipidemia/lipid-lowering therapy + impaired renal function/damage both in the overall cohort with MS and in the subgroups by left ventricular ejection fraction. Patients with HF with preserved ejection fraction, compared with other phenotypes, had a higher frequency of combinations with 3 main criteria in the composition. Patients with metabolic syndrome (MS) had a significantly higher risk of hospitalization for cardiovascular causes (odds ratio 1,142, 95% confidence interval 1,033-1,263) than patients without MS (p=0,01). Among the identified MS clusters, cluster 1 was characterized by older patient age, a greater burden of kidney impairment/damage, and the poorest prognosis. Conclusion. A high prevalence of individual MS components was found among patients with heart failure. MS was diagnosed in 70,4% of cases. The broad profile of the obtained combinations of MS components reflects the diversity of metabolic disorders in HF patients. MS was associated with a significantly increased risk of hospitalization for cardiovascular causes compared to patients without MS. Cluster analysis demonstrated heterogeneity of patients with MS in clinical characteristics and prognosis.
- 23 September 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (10S) , 7127
Open AccessPrevalence, clinical, and prognostic role of metabolic syndrome in patients with heart failure: A subanalysis of the PRIORITY-HF study
Aim. To assess the prevalence of individual components of metabolic syndrome (MS), the incidence of MS, and its clinical and prognostic significance in outpatients with heart failure (HF). Material and methods. This retrospective analysis of data from the PRIORITY-HF multicenter registry study of patients with HF in the Russian Federation was conducted. The analytical cohort included 19939 patients, and the primary and secondary criteria of MS were analyzed. A group with MS was identified according to diagnostic criteria, and combinations of components were assessed. In addition, cluster analysis was performed, and prognosis was evaluated. Results. In the analyzed cohort, the primary criteria of MS were identified with high frequency as follows: obesity in 45,6%, HTN in 89%, and type 2 diabetes in 27,4% of patients. Among the additional criteria, the highest prevalence was observed for dyslipidemia/lipid-lowering therapy in 80,7%, impaired renal function/damage in 62%, and hyperuricemia/urate-lowering therapy in only 5% of patients. MS was diagnosed in 14403 (70,4%) patients. Among patients with MS, the following distribution was noted depending on the burden of main criteria: 48,8% — 2, 28% — 1, and 23,2% — 3 main criteria. The most frequent combination was HTN + dyslipidemia/lipid-lowering therapy + impaired renal function/damage both in the overall cohort with MS and in the subgroups by left ventricular ejection fraction. Patients with HF with preserved ejection fraction, compared with other phenotypes, had a higher frequency of combinations with 3 main criteria in the composition. Patients with metabolic syndrome (MS) had a significantly higher risk of hospitalization for cardiovascular causes (odds ratio 1,142, 95% confidence interval 1,033-1,263) than patients without MS (p=0,01). Among the identified MS clusters, cluster 1 was characterized by older patient age, a greater burden of kidney impairment/damage, and the poorest prognosis. Conclusion. A high prevalence of individual MS components was found among patients with heart failure. MS was diagnosed in 70,4% of cases. The broad profile of the obtained combinations of MS components reflects the diversity of metabolic disorders in HF patients. MS was associated with a significantly increased risk of hospitalization for cardiovascular causes compared to patients without MS. Cluster analysis demonstrated heterogeneity of patients with MS in clinical characteristics and prognosis.
- Open Access
- 18 September 2026
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 101,p. 8-21
Analysis of medical students' knowledge about bronchial asthma: a multicenter study ASSA-IV
Introduction. The high prevalence of asthma in the general population necessitates the assessment of medical students' theoretical knowledge regarding the pathogenesis, diagnosis, and management of this disease. Aim. To determine the level of basic knowledge among senior medical students across key thematic blocks of asthma. Materials and methods. The fourth stage of the multicenter study "The Assessment of Physicians' (Medical Students') Knowledge in the Field of Bronchial Asthma" (ASSA) was conducted between October 2023 and May 2025 using a validated, author-developed questionnaire based on current national and international clinical guidelines. The questionnaire consistedof 21 questions divided into two blocks: "Etiopathogenesis" and "Pharmacotherapy". Results. A total of 487 correctly completed questionnaires from 5 universities of the Russian Federation were analyzed. The average rate of correct answers (ARC) for the entire questionnaire was 69.9 % (95 % CI 68.5–71.3 %), with a median (Me) of 70.6 % [IQR: 59.5%–82.5 %]. In the "Etiopathogenesis" section, the ARC reached 84.0% (95% CI 82.5–85.4 %), whereas in the "Pharmacotherapy" section it was only 59.3 % (95 % CI 57.6–61.0 %). The maximum ARC values were obtained for questions regarding asthma control levels (96.3 %) and the definition of the term "status asthmaticus" (92.6 %). Conversely, the minimum values were recorded for questions concerning sublingual immunotherapy for house dust mite allergies (16.2 %) and add-on therapy at the 4 th step of treatment (27.7%). Significant inter-center differences were revealed across the entire questionnaire (H (4) = 53.263, p < 0.001, ε2 = 0.102) and its individual sections. When compared with the previous stage (ASSA-III), a statistically significant improvement in the results was observed: the overall ARC increased by 3.9 % (69.9 % vs. 66.0 %, p < 0.001), though the effect size remained weak (r = 0.119; CLES = 0.568). Conclusion. Senior medical students demonstrated a proficient level of knowledge regarding the etiopathogenesis and diagnosis of asthma, whereas their understanding of its pharmacotherapy remains insufficient. The significant inter-center variability in the average rate of correct answers underscores the urgent need to standardize educational methods and strengthen practical training in asthma management and treatment selection.
- 18 September 2026
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 101,p. 8-21
Open AccessAnalysis of medical students' knowledge about bronchial asthma: a multicenter study ASSA-IV
Introduction. The high prevalence of asthma in the general population necessitates the assessment of medical students' theoretical knowledge regarding the pathogenesis, diagnosis, and management of this disease. Aim. To determine the level of basic knowledge among senior medical students across key thematic blocks of asthma. Materials and methods. The fourth stage of the multicenter study "The Assessment of Physicians' (Medical Students') Knowledge in the Field of Bronchial Asthma" (ASSA) was conducted between October 2023 and May 2025 using a validated, author-developed questionnaire based on current national and international clinical guidelines. The questionnaire consistedof 21 questions divided into two blocks: "Etiopathogenesis" and "Pharmacotherapy". Results. A total of 487 correctly completed questionnaires from 5 universities of the Russian Federation were analyzed. The average rate of correct answers (ARC) for the entire questionnaire was 69.9 % (95 % CI 68.5–71.3 %), with a median (Me) of 70.6 % [IQR: 59.5%–82.5 %]. In the "Etiopathogenesis" section, the ARC reached 84.0% (95% CI 82.5–85.4 %), whereas in the "Pharmacotherapy" section it was only 59.3 % (95 % CI 57.6–61.0 %). The maximum ARC values were obtained for questions regarding asthma control levels (96.3 %) and the definition of the term "status asthmaticus" (92.6 %). Conversely, the minimum values were recorded for questions concerning sublingual immunotherapy for house dust mite allergies (16.2 %) and add-on therapy at the 4 th step of treatment (27.7%). Significant inter-center differences were revealed across the entire questionnaire (H (4) = 53.263, p < 0.001, ε2 = 0.102) and its individual sections. When compared with the previous stage (ASSA-III), a statistically significant improvement in the results was observed: the overall ARC increased by 3.9 % (69.9 % vs. 66.0 %, p < 0.001), though the effect size remained weak (r = 0.119; CLES = 0.568). Conclusion. Senior medical students demonstrated a proficient level of knowledge regarding the etiopathogenesis and diagnosis of asthma, whereas their understanding of its pharmacotherapy remains insufficient. The significant inter-center variability in the average rate of correct answers underscores the urgent need to standardize educational methods and strengthen practical training in asthma management and treatment selection.
- Open Access
- 12 August 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (4) , 719-727
Experience in treating severe community-acquired pneumonia with suppurative complications
Severe community-acquired pneumonia (SCAP) remains a global medical and social problem, consistently ranking as a leading cause of admission to intensive care units (ICUs) and mortality. The severity criteria for pneumonia, as defined by international guidelines (IDSA/ATS) and Russian clinical recommendations, include the need for respiratory support, the presence of septic shock signs, and organ dysfunction. These factors necessitate a shift in treatment strategy, typically involving a revision of systemic antibiotic therapy and the implementation of measures to support vital bodily functions. Of particular significance are SCAP complications involving lung tissue destruction, such as the formation of lung abscesses, pleural empyema, and bronchopleural fistulas, which require a multidisciplinary approach to management. The aim was to present and analyze clinical experience in managing patients with severe community-acquired pneumonia complicated by suppurative processes. This includes evaluating the efficacy of applied diagnostic and therapeutic algorithms utilizing systemic antimicrobial and efferent therapy alongside invasive drainage procedures. Conclusion . Successful management of severe community-acquired pneumonia with suppurative complications requires a multidisciplinary approach. Key factors include timely adjustment of antibacterial therapy, the use of detoxification methods (e.g., lipopolysaccharide sorption), and early surgicaldrainage. The integration of conservative and invasive methods within a collaborative teamwork can improve outcomes in this category of patients.
- 12 August 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (4) , 719-727
Open AccessExperience in treating severe community-acquired pneumonia with suppurative complications
Severe community-acquired pneumonia (SCAP) remains a global medical and social problem, consistently ranking as a leading cause of admission to intensive care units (ICUs) and mortality. The severity criteria for pneumonia, as defined by international guidelines (IDSA/ATS) and Russian clinical recommendations, include the need for respiratory support, the presence of septic shock signs, and organ dysfunction. These factors necessitate a shift in treatment strategy, typically involving a revision of systemic antibiotic therapy and the implementation of measures to support vital bodily functions. Of particular significance are SCAP complications involving lung tissue destruction, such as the formation of lung abscesses, pleural empyema, and bronchopleural fistulas, which require a multidisciplinary approach to management. The aim was to present and analyze clinical experience in managing patients with severe community-acquired pneumonia complicated by suppurative processes. This includes evaluating the efficacy of applied diagnostic and therapeutic algorithms utilizing systemic antimicrobial and efferent therapy alongside invasive drainage procedures. Conclusion . Successful management of severe community-acquired pneumonia with suppurative complications requires a multidisciplinary approach. Key factors include timely adjustment of antibacterial therapy, the use of detoxification methods (e.g., lipopolysaccharide sorption), and early surgicaldrainage. The integration of conservative and invasive methods within a collaborative teamwork can improve outcomes in this category of patients.
- Open Access
- 16 July 2026
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 3 (2S) , 241-268
Follow-up of patients with interstitial lung diseases by a primary care physician. Guidelines
Interstitial lung diseases are a heterogeneous group of pathologies, the most common of which is idiopathic pulmonary fibrosis. The causes of interstitial diseases often remain unknown, but their pathogenesis is based on the gradual replacement of normal lung tissue with fibrous tissue. More than half of patients with interstitial lung diseases experience fibrosis progression, worsening symptoms, and the onset of respiratory failure within 2 years of diagnosis. Early diagnosis and timely follow-up are the primary means of disease management, particularly for idiopathic pulmonary fibrosis. This includes slowing disease progression, reducing the frequency and severity of exacerbations, and reducing the risk of developing and progressing different acute and chronic conditions that can affect respiratory symptoms and the prognosis of interstitial lung diseases. These guidelines are intended for primary care physicians, general practitioners, nurses working with these physicians, and paramedics at primary care facilities performing the doctor functions, including conducting outpatient follow-up. These guidelines are also intended for specialists such as pulmonologists, allergists/ immunologists, and other specialists involved in the care of patients with interstitial lung diseases. In addition, these guidelines are intended for heads of healthcare facilities (or its divisions) providing primary care, as well as students, residents, and postgraduate students at medical and pharmaceutical educational institutions.
- 16 July 2026
- Published by Silicea - Poligraf, LLC in Primary Health Care (Russian Federation)
- Vol. 3 (2S) , 241-268
Open AccessFollow-up of patients with interstitial lung diseases by a primary care physician. Guidelines
Interstitial lung diseases are a heterogeneous group of pathologies, the most common of which is idiopathic pulmonary fibrosis. The causes of interstitial diseases often remain unknown, but their pathogenesis is based on the gradual replacement of normal lung tissue with fibrous tissue. More than half of patients with interstitial lung diseases experience fibrosis progression, worsening symptoms, and the onset of respiratory failure within 2 years of diagnosis. Early diagnosis and timely follow-up are the primary means of disease management, particularly for idiopathic pulmonary fibrosis. This includes slowing disease progression, reducing the frequency and severity of exacerbations, and reducing the risk of developing and progressing different acute and chronic conditions that can affect respiratory symptoms and the prognosis of interstitial lung diseases. These guidelines are intended for primary care physicians, general practitioners, nurses working with these physicians, and paramedics at primary care facilities performing the doctor functions, including conducting outpatient follow-up. These guidelines are also intended for specialists such as pulmonologists, allergists/ immunologists, and other specialists involved in the care of patients with interstitial lung diseases. In addition, these guidelines are intended for heads of healthcare facilities (or its divisions) providing primary care, as well as students, residents, and postgraduate students at medical and pharmaceutical educational institutions.
- Open Access
- 4 June 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (4) , 6424
Incidence of chronic obstructive pulmonary disease in the newly diagnosed microalbuminuria population: retrospective analysis of the AURA registry database
Aim. To analyze the phenotypes of patients at highest risk for albuminuria (AU) in a population of patients without diabetes and to estimate its prevalence in the identified phenotypes. Material and methods. A total of 4580 patients over 40 years of age without type 1 or 2 diabetes, who had not previously been diagnosed with chronic kidney disease, were included in a real-world practice registry of AU detection in patients with previously undiagnosed CKD — AURA. The registry design did not include patient follow-up. AU was determined using sensitive micral-test strips, with an AU cutoff of 20 mg/L. Results. AU ≥20 mg/L was present in 64,9% of cases. According to univariate analysis, patients with AU compared with those without it were more likely to have the following risk factors: hypertension (79% vs 71,5%), male sex (44,2% vs 38,6%), smoking (31% vs 25,2%), metabolic syndrome (32% vs 23,4%), as well as diseases such as coronary artery disease (35,5% vs 29,7%), heart failure (41,5% vs 35%), atrial fibrillation (17,3% vs 12,5%), prediabetes (14,7% vs 8,9%), chronic obstructive pulmonary disease (COPD) (7,67% vs 3,76%), chronic cystitis (5,35% vs 3,49%). A multivariate model revealed that age (with each 1-year increase in age, the risk of AU increased by 2%, p-value Conclusion. A multivariate analysis of AURA registry data confirmed that AU is independently associated with conditions such as post-infarction cardiosclerosis, atrial fibrillation, prediabetes, metabolic syndrome, chronic cystitis, and COPD. Of particular interest is the study and follow-up of patients with COPD, in whom AU was found in 78,9%.
- 4 June 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (4) , 6424
Open AccessIncidence of chronic obstructive pulmonary disease in the newly diagnosed microalbuminuria population: retrospective analysis of the AURA registry database
Aim. To analyze the phenotypes of patients at highest risk for albuminuria (AU) in a population of patients without diabetes and to estimate its prevalence in the identified phenotypes. Material and methods. A total of 4580 patients over 40 years of age without type 1 or 2 diabetes, who had not previously been diagnosed with chronic kidney disease, were included in a real-world practice registry of AU detection in patients with previously undiagnosed CKD — AURA. The registry design did not include patient follow-up. AU was determined using sensitive micral-test strips, with an AU cutoff of 20 mg/L. Results. AU ≥20 mg/L was present in 64,9% of cases. According to univariate analysis, patients with AU compared with those without it were more likely to have the following risk factors: hypertension (79% vs 71,5%), male sex (44,2% vs 38,6%), smoking (31% vs 25,2%), metabolic syndrome (32% vs 23,4%), as well as diseases such as coronary artery disease (35,5% vs 29,7%), heart failure (41,5% vs 35%), atrial fibrillation (17,3% vs 12,5%), prediabetes (14,7% vs 8,9%), chronic obstructive pulmonary disease (COPD) (7,67% vs 3,76%), chronic cystitis (5,35% vs 3,49%). A multivariate model revealed that age (with each 1-year increase in age, the risk of AU increased by 2%, p-value Conclusion. A multivariate analysis of AURA registry data confirmed that AU is independently associated with conditions such as post-infarction cardiosclerosis, atrial fibrillation, prediabetes, metabolic syndrome, chronic cystitis, and COPD. Of particular interest is the study and follow-up of patients with COPD, in whom AU was found in 78,9%.
- Open Access
- 27 March 2026
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 7 (1) , 62-68
Evaluation of the effectiveness of pectin with trepang extract in the complex therapy of NSAID-associated lesions of the upper gastrointestinal tract
Objective: to evaluate the clinical efficacy of a biologically active pectin supplement with trepang extract in patients with NSAID-associated upper gastrointestinal lesions. Material and methods: a prospective observational study included patients aged 18–75 years with NSAID-associated upper gastrointestinal lesions. We compared two groups of patients: the first group (n=25) received a combination of standard medications and a pectin complex with trepang extract, while the second group (n=25) received standard therapy in accordance with clinical guidelines. Results : the group of patients receiving the combination therapy showed statistically significant improvements in treatment outcomes . Conclusion: the use of a pectin complex with trepang extract as an adjunct to standard therapy enhances the effectiveness of treating NSAID-related gastropathies.
- 27 March 2026
- Published by Rostov State Medical University in South Russian Journal of Therapeutic Practice
- Vol. 7 (1) , 62-68
Open AccessEvaluation of the effectiveness of pectin with trepang extract in the complex therapy of NSAID-associated lesions of the upper gastrointestinal tract
Objective: to evaluate the clinical efficacy of a biologically active pectin supplement with trepang extract in patients with NSAID-associated upper gastrointestinal lesions. Material and methods: a prospective observational study included patients aged 18–75 years with NSAID-associated upper gastrointestinal lesions. We compared two groups of patients: the first group (n=25) received a combination of standard medications and a pectin complex with trepang extract, while the second group (n=25) received standard therapy in accordance with clinical guidelines. Results : the group of patients receiving the combination therapy showed statistically significant improvements in treatment outcomes . Conclusion: the use of a pectin complex with trepang extract as an adjunct to standard therapy enhances the effectiveness of treating NSAID-related gastropathies.
- 18 February 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (1)
Diagnosis of pulmonary sequestration and systemic arterial anomalies: case report
Pulmonary sequestration (PS) is a developmental anomaly of lung tissue in which the abnormally developed section is disconnected from the normal bronchial system and is supplied by branches of aberrant vessels. Clinical manifestations of this defect typically begin in childhood, but diagnosing PS in adults is also possible. Visualization of the aberrant vessel supplying the pathological section is of important diagnostic value. The aim of this study was to demonstrate the feasibility of diagnosing late-onset PS. Conclusion. The presented clinical observation highlights the complexities and sequence of diagnostic and differential diagnosis steps for a rare pulmonary anomaly presenting as community-acquired pneumonia.
- 18 February 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (1)
Diagnosis of pulmonary sequestration and systemic arterial anomalies: case report
Pulmonary sequestration (PS) is a developmental anomaly of lung tissue in which the abnormally developed section is disconnected from the normal bronchial system and is supplied by branches of aberrant vessels. Clinical manifestations of this defect typically begin in childhood, but diagnosing PS in adults is also possible. Visualization of the aberrant vessel supplying the pathological section is of important diagnostic value. The aim of this study was to demonstrate the feasibility of diagnosing late-onset PS. Conclusion. The presented clinical observation highlights the complexities and sequence of diagnostic and differential diagnosis steps for a rare pulmonary anomaly presenting as community-acquired pneumonia.
- Open Access
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4672
Meeting of the Internal Medicine Sciences’ Council of the Department of Medical Sciences of the Russian Academy of Sciences on April 29, 2025, "Marathon of Research Projects from Russian Internal Medicine Departments: 'From Innovative Technologies and Education to Healthcare Practice'. Application of Personalized Medicine Approaches in Internal Medicine Practice"
Заседание Совета по терапевтическим наукам Отделения медицинских наук РАН от 29.04.2025: Марафон научных проектов терапевтических кафедр России "От инновационных технологий и образования к практике здравоохранения. Применение подходов персонализированной медицины в терапевтической практике"
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4672
Open AccessMeeting of the Internal Medicine Sciences’ Council of the Department of Medical Sciences of the Russian Academy of Sciences on April 29, 2025, "Marathon of Research Projects from Russian Internal Medicine Departments: 'From Innovative Technologies and Education to Healthcare Practice'. Application of Personalized Medicine Approaches in Internal Medicine Practice"
Заседание Совета по терапевтическим наукам Отделения медицинских наук РАН от 29.04.2025: Марафон научных проектов терапевтических кафедр России "От инновационных технологий и образования к практике здравоохранения. Применение подходов персонализированной медицины в терапевтической практике"
- 12 December 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 50-62
Pharmacotherapy of chronic obstructive pulmonary disease: Assessment of knowledge of doctors and senior students. Results of the ASCO III study
Introduction. Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality worldwide. The global prevalence of COPD is estimated at 10.3%. In Russia, there are more than 4 million patients with COPD, with 40% requiring hospitalization and 14% needing rehospitalization. Such statistics highlight the significance of COPD. Aim. To assess the level of knowledge among physicians and senior medical students regarding COPD pharmacotherapy. Mat erials and methods. This article presents an analysis of data on the knowledge assessment and preferences of specialists and senior medical students regarding COPD pharmacotherapy, obtained during the multicenter ASCO III study conducted between 2019 and 2023. Results. A total of 420 physician questionnaires from 11 regions and 372 student questionnaires from 7 medical universities were analyzed. The average level of correct answers (LCA) was 56.1% among physicians and 41.6% among students (p < 0.001). Respondents demonstrated the best results in questions related to the combination of drugs in a single delivery device. The poorest results were observed in questions regarding the choice of baseline therapy for severe COPD symptoms and the optimal selection of antibacterial agents during disease exacerbations. Correlation analysis of the relationship between “LCA” and “Years of Experience” among physicians revealed a weak inverse correlation between specialists’ knowledge level and their work experience. Conclusions. A relatively low level of knowledge in COPD pharmacotherapy was identified among both physicians and students. Physicians demonstrated significantly better knowledge than students in most areas. According to the authors, there is a need for continued assessment of knowledge in real-world practice and the optimization of both core and supplementary educational activities in this field.
- 12 December 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 20,p. 50-62
Pharmacotherapy of chronic obstructive pulmonary disease: Assessment of knowledge of doctors and senior students. Results of the ASCO III study
Introduction. Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality worldwide. The global prevalence of COPD is estimated at 10.3%. In Russia, there are more than 4 million patients with COPD, with 40% requiring hospitalization and 14% needing rehospitalization. Such statistics highlight the significance of COPD. Aim. To assess the level of knowledge among physicians and senior medical students regarding COPD pharmacotherapy. Mat erials and methods. This article presents an analysis of data on the knowledge assessment and preferences of specialists and senior medical students regarding COPD pharmacotherapy, obtained during the multicenter ASCO III study conducted between 2019 and 2023. Results. A total of 420 physician questionnaires from 11 regions and 372 student questionnaires from 7 medical universities were analyzed. The average level of correct answers (LCA) was 56.1% among physicians and 41.6% among students (p < 0.001). Respondents demonstrated the best results in questions related to the combination of drugs in a single delivery device. The poorest results were observed in questions regarding the choice of baseline therapy for severe COPD symptoms and the optimal selection of antibacterial agents during disease exacerbations. Correlation analysis of the relationship between “LCA” and “Years of Experience” among physicians revealed a weak inverse correlation between specialists’ knowledge level and their work experience. Conclusions. A relatively low level of knowledge in COPD pharmacotherapy was identified among both physicians and students. Physicians demonstrated significantly better knowledge than students in most areas. According to the authors, there is a need for continued assessment of knowledge in real-world practice and the optimization of both core and supplementary educational activities in this field.